See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Natural Disasters
Trade War
Donald Trump
Social Media
Baseball
Stock Markets
Artificial Intelligence
Education
Soccer
Trade
Property
Published • loading... • Updated

Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs

Summary by biopharmadive.com
More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed via rounds worth at least $100 million, which experts believe reflects a strategic shift.

1 Articles

All
Left
Center
1
Right
biopharmadive.combiopharmadive.com
Center

Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed via rounds worth at least $100 million, which experts believe reflects a strategic shift.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Thursday, April 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Biotech

Biotech

Startups

Startups

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal